These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35024332)

  • 1. Anaplastic multiple myeloma with MYC rearrangement.
    Ichikawa S; Fukuhara N; Hashimoto K; Fujishima F; Ichinohasama R; Harigae H
    Leuk Res Rep; 2022; 17():100288. PubMed ID: 35024332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multiple myeloma with IgH::MYC and multiple extramedullary lesions].
    Sasaki Y; Ichikawa S; Sakurai K; Nakamura H; Inokura K; Onodera K; Fukuhara N; Onishi Y; Yokoyama H; Harigae H
    Rinsho Ketsueki; 2024; 65(3):147-152. PubMed ID: 38569857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late Relapse of Multiple Myeloma with Testicular Plasmacytoma after Autologous Hematopoietic Stem Cell Transplantation: A Case Report and Review of the Literature.
    Wei ZL; Pan CM; Jiang YZ; Yan-Dai ; Huanguang LQ; Huang DP
    Ann Clin Lab Sci; 2018 Jan; 48(1):120-125. PubMed ID: 29531008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaplastic Multiple Myeloma: Case Series and Literature Review.
    Wu J; Chu E; Chase CC; Choi T; Gasparetto C; Young K; Kang Y
    Asploro J Biomed Clin Case Rep; 2022; 5(1):1-11. PubMed ID: 35224465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors in newly diagnosed multiple myeloma patients with 1q21 amplification/gain treated with bortezomib-based regimens followed by autologous hematopoietic stem cell transplantation].
    Huang WY; Zou DH; Liu W; An G; Xu Y; Sui WW; Deng SH; Li CW; Liu H; Li J; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):496-500. PubMed ID: 30032568
    [No Abstract]   [Full Text] [Related]  

  • 6. The combination of C-Myc rearrangement and 1q21 gain is associated with poor prognosis in multiple myeloma.
    Jin Y; Yu X; Du J; Li H; Tang W; Jia C; Zan Y; Chen M; Zhang Y; Yu M; Rong W; Zhou D; Zhuang J
    Ann Hematol; 2021 May; 100(5):1251-1260. PubMed ID: 33686491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation of double-hit follicular lymphoma to plasmablastic lymphoma: a partial role of MYC gene rearrangement.
    Ise M; Kageyama H; Ikebe D; Araki A; Kumagai K; Itami M
    J Clin Exp Hematop; 2018 Sep; 58(3):128-135. PubMed ID: 30012920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaplastic multiple myeloma resembling dysplastic megakaryocytes.
    Xie W; Tang G; Li S; Yin CC; Xu J
    Clin Case Rep; 2020 Mar; 8(3):568-569. PubMed ID: 32185061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotypic and cytogenetic findings of B-lymphoblastic leukemia/lymphoma associated with combined IGH/BCL2 and MYC rearrangement.
    Kelemen K; Holden J; Johnson LJ; Davion S; Robetorye RS
    Cytometry B Clin Cytom; 2017 Jul; 92(4):310-314. PubMed ID: 26517296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical rearrangement involving 3'-IGH@ and a breakpoint at least 400 Kb upstream of an intact MYC in a CLL patient with an apparently balanced t(8;14)(q24.1;q32) and negative MYC expression.
    Amarillo I; Bui PH; Kantarci S; Rao N; Shackley BS; García R; Tirado CA
    Mol Cytogenet; 2013 Feb; 6(1):5. PubMed ID: 23369149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of MYC Rearrangements in Newly Diagnosed Multiple Myeloma.
    Abdallah N; Baughn LB; Rajkumar SV; Kapoor P; Gertz MA; Dispenzieri A; Lacy MQ; Hayman SR; Buadi FK; Dingli D; Go RS; Hwa YL; Fonder A; Hobbs M; Lin Y; Leung N; Kourelis T; Warsame R; Siddiqui M; Lust J; Kyle RA; Ketterling R; Bergsagel L; Greipp P; Kumar SK
    Clin Cancer Res; 2020 Dec; 26(24):6581-6588. PubMed ID: 33008815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic aberrations in anaplastic multiple myeloma: high frequency of 1q21(CKS1B) amplifications.
    Bahmanyar M; Qi X; Chang H
    Leuk Res; 2013 Dec; 37(12):1726-8. PubMed ID: 24169086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant lymphoma with c-myc gene rearrangement in a patient receiving long-term treatment for multiple myeloma].
    Ohnishi H; Kamimura T; Gondo H; Okamura T; Niho Y; Yao T
    Rinsho Ketsueki; 1999 Dec; 40(12):1265-70. PubMed ID: 10658480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trial.
    Nemec P; Zemanova Z; Kuglik P; Michalova K; Tajtlova J; Kaisarova P; Oltova A; Filkova H; Holzerova M; Balcarkova J; Jarosova M; Rabasova J; Hruba M; Spicka I; Gregora E; Adam Z; Scudla V; Maisnar V; Schutzova M; Hajek R;
    Leuk Lymphoma; 2012 May; 53(5):920-7. PubMed ID: 22023516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaplastic multiple myeloma: possible limitations of conventional chemotherapy for long-term remission.
    Ichikawa S; Fukuhara N; Hatta S; Himuro M; Nasu K; Ono K; Okitsu Y; Kobayashi M; Onishi Y; Ri M; Ichinohasama R; Harigae H
    J Clin Exp Hematop; 2018; 58(1):39-42. PubMed ID: 29553093
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of 1q21 amplification on bortezomib therapeutic response and prognosis of newly diagnosed multiple myeloma patients].
    Liu XL; Yang PY; Yu XY; Chen JC; Liu XL; Bai J; Liu YM; He H; Sun JN; Fan HQ; Zhang C; Zhang Y; Su KJ; Liu CS; Tan YH; Gao SJ; Li W; Jin FY
    Zhonghua Xue Ye Xue Za Zhi; 2018 May; 39(5):408-413. PubMed ID: 29779352
    [No Abstract]   [Full Text] [Related]  

  • 17. Aggressive Disease Course of Multiple Myeloma with Concomitant ALK-Negative Anaplastic Large Cell Lymphoma: A Case Report with an Unusual Presentation.
    Staderini M; Mannelli L; Antonioli E; Puccini B; Berti V; Mungai F; Vergoni F; Carrai V; Rigacci L; Bosi A
    Case Rep Hematol; 2020; 2020():6309736. PubMed ID: 32509362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-Hit Primary Plasma Cell Leukemia with
    Yasumi M; Endo T; Sata H; Karasuno T
    Case Rep Hematol; 2020; 2020():8811114. PubMed ID: 33381329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-MYC rearrangement may induce an aggressive phenotype in anaplastic lymphoma kinase positive anaplastic large cell lymphoma: Identification of a novel fusion gene ALO17/C-MYC.
    Moritake H; Shimonodan H; Marutsuka K; Kamimura S; Kojima H; Nunoi H
    Am J Hematol; 2011 Jan; 86(1):75-8. PubMed ID: 21080342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High intensity regimens with autologous hematopoietic stem cell transplantation as treatment of multiple myeloma.
    Awedan AA
    Ann Transplant; 2002; 7(2):38-43. PubMed ID: 12416471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.